A vs TMO: fair value comparison
Agilent Technologies, Inc. and Thermo Fisher Scientific Inc. · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, A currently sits closer to the top of our discount ranking.
| A | TMO | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $153.84 | $622.18 |
| 12-month range | $114.52–$150.10 | $469.21–$592.51 |
| Sector rank | #64 of 113 Healthcare | #66 of 113 Healthcare |
| Quality grade | C | C |
| Momentum grade | — | A |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Stable |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: A fair value analysis · TMO fair value analysis